Eptoin Suspension contains Phenytoin 30mg/5ml, an antiepileptic agent primarily used in the management and prevention of generalized tonic-clonic (grand mal) seizures and complex partial seizures. Phenytoin acts by stabilizing neuronal membranes and decreasing seizure activity by increasing efflux or decreasing influx of sodium ions across cell membranes in the motor cortex during generation of nerve impulses. This suspension formulation allows for precise dosing in pediatric and adult patients who require an oral liquid preparation. Eptoin Suspension is indicated for the control of seizures in epilepsy, particularly when oral tablet administration is not feasible. It is essential to administer the medication consistently with regard to meals to maintain stable plasma concentrations. Dosage should be individualized based on clinical response and serum phenytoin levels, with careful monitoring to avoid toxicity, which may present as nystagmus, ataxia, or cognitive impairment. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be reviewed due to phenytoin’s enzyme-inducing properties. Eptoin Suspension should be stored at controlled room temperature and protected from light. Use under medical supervision is mandatory to ensure efficacy and safety in seizure management.